CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells.

  • H H Jabara
    Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115.
  • S M Fu
    Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115.
  • R S Geha
    Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115.
  • D Vercelli
    Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115.

この論文をさがす

抄録

<jats:p>A novel pathway of IgE-B cell differentiation has been identified. Engagement of the B cell antigen CD40 by F(ab')2 fragments of monoclonal antibody (mAb) 626.1 in the presence of recombinant interleukin 4 (rIL-4) induced intense IgE synthesis, but modest IgG synthesis, by highly purified human B cells. Surface IgE- B cells isolated by cell sorting were induced to produce IgE by mAb 626.1 and IL-4. Thus, IgE synthesis is unlikely to result from expansion of a B cell population precommitted to IgE in vivo. A neutralizing anti-IL-6 antibody strongly, but not completely, inhibited the IgE response. This indicates that autocrine production of IL-6 plays an important amplification role in IgE synthesis triggered by anti-CD40 mAb and IL-4. Although the exact role played by CD40 in IgE responses in vivo remains to be established, this T cell-independent system represents a useful model to characterize the biochemical and molecular events leading to IgE synthesis in human B cells.</jats:p>

収録刊行物

被引用文献 (11)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ